Calculus VCT plc, formerly known as Investec Structured Products Calculus VCT PLC, is a venture capital trust specializing in venture capital investments.

Calculus VCT plc

Calculus Capital is a company that offers EIS and VCT investment products, focusing on backing businesses across the fastest growing sectors of the UK economy including technology, healthcare and the environment.

Calculus Capital

Calculus specialises in creating and managing venture capital funds for individuals. Calculus is a pioneer in the tax-efficient industry having set up the UK’s first approved EIS fund in 1999. Through the Calculus EIS Fund, Calculus VCT and Calculus Knowledge EIS Fund - investors can access a diverse portfolio of innovative UK companies.

Important note: EIS and VCT investments are high risk and capital is at risk. Past performance is not indicative of future performance. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future.

Calculus Capital is authorised and regulated by the Financial Conduct Authority.

Synpromics Ltd

Scancell

Yourgene Health

Epistem

Arecor

Money Dashboard

C4X Discovery

Avvio

Horizon Discovery

Human Race

Inspiresport

Cloud Trade

Collagen Solutions

I am very pleased to announce Calculus' takeover of Great Point Media’s film and television production finance business, Illium. Illium has solid potential as an ongoing business providing secured financing for film and TV productions. We look forward to working closely with producers and our shareholders. Thanks to our incredible Calculus team for all their hard work over many weeks to make this possible.

How can investors prepare for a new political landscape? Read our election response, by Director Matthew Moynes here ⬇ 

https://lnkd.in/emxv2awK

The first Calculus Knowledge Intensive EIS Fund has been successfully fully deployed in just 11 months, we now have an exciting and diverse portfolio of healthcare and technology companies. 

'We focus on those companies which are the ‘doers,’ the innovators, the experts and the game changers.'

Congratulations on your BAFTA nomination for Evacuation, Wonderhood Studios 🏆 
We are so proud of the calibre of companies within our entertainment portfolio and the award nominations are a very well deserved endorsement.

Yesterday marked International Day of Women and Girls in Science, a celebration of the women who are blazing ahead to tackle the world’s toughest health challenges and discovering new scientific innovations.

We want to take this opportunity to thank and celebrate the inspirational women driving progress and innovation in #STEM, here at the Arecor Group and around the world.

Hear from some of the brilliant women working at Arecor Group, including our CEO Sarah Howell, and what it means to be a part of a successful women-led and diverse company culture, inspiring the next generation of female scientists.

https://lnkd.in/eHAB_qET

#Arecor #WomenInScience and #GirlsInSTEM

Amazing to see the growth and development of Calculus Capital portfolio company Laverock Therapeutics.

Read more: https://lnkd.in/grGcupd4

msh id	COM:CALCULUSCAPITAL
symbol	CLC
name	Calculus VCT plc
homepage url	https://www.calculuscapital.com/calculus-vct-plc/
country	GB
sector	Financial Services
industry	Asset Management
market	STOCKS
employee count	-
crunchbase url	-
linkedin url	-
founders	-

market cap	527.65K
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.24
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-0.67
growth ebitda ratio	-0.24
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.24
growth gross profit	-0.56
growth gross profit ratio	-

COM:CALCULUSCAPITAL

Calculus Capital

Last Close

58.00

21/10 13:32

Market Cap

407.19K

Beta: -

Volume Today

29.96K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	402.94K
cost of revenue	402.94K
depreciation and amortization	-
ebitda	813.42K
ebitda ratio	0.67
eps	0.02
eps diluted	0.02
operating expenses	402.94K
operating income	813.42K
operating income ratio	0.67

accounts receivables	-
capital expenditure	-
cash at beginning of period	7.35M
cash at end of period	4.74M
inventory	-
working capital ttm	3.57M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-